Dror Bashan

President and CEO, Director, Protalix BioTherapeutics, Inc.

Bought, 12 months

$0.1M

Sold, 12 months

$0.0M

Companies

Latest trade

Dec 19, 2025

Companies

Protalix BioTherapeutics, Inc.President and CEO, Director +$0.1M

Trades

PLX Bought 56,000 shares at $1.81 $0.1M Dec 19

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.